Chin-Kuo Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chin-Kuo Chen has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Li-Chun Hsieh
Department of Otolaryngology-Head and Neck Surgery, Mackay Memorial Hospital, Taipei 104217, Taiwan
5 shared publications - Po-Hsiang Tsui
Department of Medical Imaging and Radiological Sciences, Chang Gung University, Taoyuan, Taiwan
4 shared publications - Mien-Jen Lin
Department of Medical Education, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan
3 shared publications Li-Chun Hsieh
Department of Otolaryngology Head and Neck Surgery, Mackay Memorial Hospital, Taipei, Taiwan
2 shared publications- Yung-Liang Wan
Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University
2 shared publications - Chen-Yu Chien
Department of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
1 shared publication
Latest Publications
- Open Access
Multidimensional Evaluation of Guideline-Based Generative Artificial Intelligence Responses in Traditional Chinese: A Ménière’s Disease Study
Background: The reliability of generative artificial intelligence for Chinese medical information remains uncertain. This study evaluates the concordance and linguistic performance of three generative artificial intelligence systems in generating Chinese information on Ménière’s disease against clinical practice guidelines. Methods: Seventeen questions, adapted from the Key Action Statements of the American Academy of Otolaryngology–Head and Neck Surgery guidelines, were posed to ChatGPT o4-mini-high, Gemini 2.5 Pro, and Grok 3 (51 total responses). Responses were assessed for guideline concordance, communication features, and readability with matched analyses (Cochran’s Q and Friedman tests), with Holm–Bonferroni correction across nine communication characteristics. Results: Correctness rates did not differ significantly among the three models (ChatGPT o4-mini-high: 100%, Gemini 2.5 Pro: 100%, Grok 3: 94.1%; Q = 2.00, p = 0.368). Six of the nine communication characteristics differed significantly, with moderate to large effect sizes (Kendall’s W = 0.26–0.76), including guideline quotation, citation quality, key point emphasis and recommendations beyond the guideline. The proportion of difficult words also differed significantly (p = 0.0033). Gemini 2.5 Pro had a lower proportion of difficult words than ChatGPT o4-mini-high (adjusted p = 0.040) and Grok 3 (adjusted p = 0.0002). Conclusion: High guideline concordance does not necessarily indicate reliable citations, effective communication, or accessible language. These findings reflect responses generated under single-query conditions rather than consistent model performance, highlighting the need for expert oversight in clinical use.
Open AccessMultidimensional Evaluation of Guideline-Based Generative Artificial Intelligence Responses in Traditional Chinese: A Ménière’s Disease Study
Background: The reliability of generative artificial intelligence for Chinese medical information remains uncertain. This study evaluates the concordance and linguistic performance of three generative artificial intelligence systems in generating Chinese information on Ménière’s disease against clinical practice guidelines. Methods: Seventeen questions, adapted from the Key Action Statements of the American Academy of Otolaryngology–Head and Neck Surgery guidelines, were posed to ChatGPT o4-mini-high, Gemini 2.5 Pro, and Grok 3 (51 total responses). Responses were assessed for guideline concordance, communication features, and readability with matched analyses (Cochran’s Q and Friedman tests), with Holm–Bonferroni correction across nine communication characteristics. Results: Correctness rates did not differ significantly among the three models (ChatGPT o4-mini-high: 100%, Gemini 2.5 Pro: 100%, Grok 3: 94.1%; Q = 2.00, p = 0.368). Six of the nine communication characteristics differed significantly, with moderate to large effect sizes (Kendall’s W = 0.26–0.76), including guideline quotation, citation quality, key point emphasis and recommendations beyond the guideline. The proportion of difficult words also differed significantly (p = 0.0033). Gemini 2.5 Pro had a lower proportion of difficult words than ChatGPT o4-mini-high (adjusted p = 0.040) and Grok 3 (adjusted p = 0.0002). Conclusion: High guideline concordance does not necessarily indicate reliable citations, effective communication, or accessible language. These findings reflect responses generated under single-query conditions rather than consistent model performance, highlighting the need for expert oversight in clinical use.
- Open Access
- 26 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 675
Postoperative Pain Following a Retroauricular Approach Versus a Transcanal Approach in Tympanoplasty Type 1: A 14-Day Retrospective Study
Objectives: This study aimed to determine whether the surgical approach used significantly affected postoperative pain and quality of life. Methods: This retrospective study included 45 adult patients undergoing type I tympanoplasty for chronic tympanic membrane perforation. The patients were divided into two groups: transcanal (n = 24) and retroauricular (n = 21). Postoperative pain was assessed using the Wong–Baker FACES® Pain Rating Scale. Additional outcomes included analgesic use and activity limitation. Results: The graft success rates in the transcanal and retroauricular groups were 95.8% and 95.2%, respectively. The transcanal group reported significantly lower pain scores between postoperative days 5 and 8 (p < 0.05) and discontinued analgesic use earlier (mean 3.1 versus 4.3 days; p < 0.05). Furthermore, the transcanal group had fewer activity limitation events during recovery. Operative time was significantly shorter in the transcanal group (55.4 ± 10.1 versus 90.2 ± 10.6 min; p < 0.001). No major complications were observed in either group. Conclusions: A transcanal approach is associated with reduced postoperative pain, earlier recovery, and shorter analgesic use than a retroauricular approach in tympanoplasty type I.
- 26 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 675
Open AccessPostoperative Pain Following a Retroauricular Approach Versus a Transcanal Approach in Tympanoplasty Type 1: A 14-Day Retrospective Study
Objectives: This study aimed to determine whether the surgical approach used significantly affected postoperative pain and quality of life. Methods: This retrospective study included 45 adult patients undergoing type I tympanoplasty for chronic tympanic membrane perforation. The patients were divided into two groups: transcanal (n = 24) and retroauricular (n = 21). Postoperative pain was assessed using the Wong–Baker FACES® Pain Rating Scale. Additional outcomes included analgesic use and activity limitation. Results: The graft success rates in the transcanal and retroauricular groups were 95.8% and 95.2%, respectively. The transcanal group reported significantly lower pain scores between postoperative days 5 and 8 (p < 0.05) and discontinued analgesic use earlier (mean 3.1 versus 4.3 days; p < 0.05). Furthermore, the transcanal group had fewer activity limitation events during recovery. Operative time was significantly shorter in the transcanal group (55.4 ± 10.1 versus 90.2 ± 10.6 min; p < 0.001). No major complications were observed in either group. Conclusions: A transcanal approach is associated with reduced postoperative pain, earlier recovery, and shorter analgesic use than a retroauricular approach in tympanoplasty type I.
- Open Access
- 29 January 2026
- Published by Springer Nature in Head & Face Medicine
- Vol. 22 (1)
Endoscopic tympanoplasty using small intestinal submucosa xenografts for large tympanic membrane perforations: a one-year retrospective cohort study with clinical follow-up
To evaluate the anatomical and audiological outcomes of endoscopic tympanoplasty using porcine small intestinal submucosal (SIS) xenografts for repairing l
- 29 January 2026
- Published by Springer Nature in Head & Face Medicine
- Vol. 22 (1)
Open AccessEndoscopic tympanoplasty using small intestinal submucosa xenografts for large tympanic membrane perforations: a one-year retrospective cohort study with clinical follow-up
To evaluate the anatomical and audiological outcomes of endoscopic tympanoplasty using porcine small intestinal submucosal (SIS) xenografts for repairing l
- 18 November 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (11) , e70714
Enterovirus A71 Co‐Opts the IQGAP1 for a Non‐Lytic Release of Viral Particles
The human enterovirus A71 (EV‐A71) is known to infect host cells, replicate, and assemble viral particles, which are released by cell lysis. However, studies have demonstrated that EV‐A71 can also exit cells via a non‐lytic pathway. Nevertheless, research on this phenomenon remains limited. The present study aims to elucidate the mechanisms by which EV‐A71 employs non‐lytic pathways to release viral particles. A combination of mass spectrometry and gene ontology analysis was utilized to identify the host protein IQGAP1 as interacting with the EV‐A71 3CD protein. The extracellular vesicles released from EV‐A71‐infected cells with IQGAP1 knockdown exhibited diminished expression of both IQGAP1 and EV‐A71 VP1 proteins, accompanied by a substantial decrease in Tsg101 level. In IQGAP1 knockout cells or after dihydroartemisinin‐mediated IQGAP1 inhibition, unclosed phagosomes were observed, impairing viral particle release. Furthermore, IQGAP1 has been found to facilitate the closure of phagosomes, thus forming virus‐containing autophagosomes and promoting the non‐lytic release of EV‐A71 particles. The mechanism of action of the EV‐A71 virus involves the exploitation of a host cell's IQGAP1 to regulate autophagy, leading to the formation of virus‐containing autophagosomes. This process ultimately results in the promotion of non‐lytic viral particle release.
- 18 November 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (11) , e70714
Enterovirus A71 Co‐Opts the IQGAP1 for a Non‐Lytic Release of Viral Particles
The human enterovirus A71 (EV‐A71) is known to infect host cells, replicate, and assemble viral particles, which are released by cell lysis. However, studies have demonstrated that EV‐A71 can also exit cells via a non‐lytic pathway. Nevertheless, research on this phenomenon remains limited. The present study aims to elucidate the mechanisms by which EV‐A71 employs non‐lytic pathways to release viral particles. A combination of mass spectrometry and gene ontology analysis was utilized to identify the host protein IQGAP1 as interacting with the EV‐A71 3CD protein. The extracellular vesicles released from EV‐A71‐infected cells with IQGAP1 knockdown exhibited diminished expression of both IQGAP1 and EV‐A71 VP1 proteins, accompanied by a substantial decrease in Tsg101 level. In IQGAP1 knockout cells or after dihydroartemisinin‐mediated IQGAP1 inhibition, unclosed phagosomes were observed, impairing viral particle release. Furthermore, IQGAP1 has been found to facilitate the closure of phagosomes, thus forming virus‐containing autophagosomes and promoting the non‐lytic release of EV‐A71 particles. The mechanism of action of the EV‐A71 virus involves the exploitation of a host cell's IQGAP1 to regulate autophagy, leading to the formation of virus‐containing autophagosomes. This process ultimately results in the promotion of non‐lytic viral particle release.
- Open Access
- 6 November 2025
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
Low Geriatric Nutritional Risk Index Predicts Unfavorable Outcomes in Older Sudden Sensorineural Hearing Loss Patients
Importance: Sudden sensorineural hearing loss (SSNHL) is associated with metabolic syndrome, central obesity, and albumin level. Malnutrition may adversely affect recovery in older patients with SSNHL, yet its clinical relevance remains underexplored. Objective: This study investigated the associations of the geriatric nutritional risk index (GNRI) with clinical outcomes in older patients (age >65 years) with SSNHL. Design: Observational retrospective study. Setting: Tertiary academic medical center. Participants: A total of 328 patients aged over 65 years who were diagnosed with SSNHL were retrospectively enrolled. Patients were included if they had complete clinical, audiometric, and laboratory data, including serum albumin levels and anthropometrics for GNRI calculation. Intervention/Exposures: The primary exposure was the GNRI, calculated using body weight, height, and serum albumin. All patients received steroid treatment for SSNHL. Main Outcome Measures: The primary outcome was hearing recovery, categorized as favorable or unfavorable based on clinical audiometric improvement. Results: Among older patients with SSNHL, 107 (32.62%) and 221 (67.38%) had favorable and unfavorable outcomes, respectively. Vertigo, worse initial level of hearing loss, and low GNRI were mainly associated with unfavorable hearing outcomes in older patients with SSNHL. Furthermore, low GNRI (P = .0151). Multivariate logistic regression revealed that vertigo (aOR = 3.45, P = .0002), worse initial level of hearing loss (per 1 unit increase in hearing loss elevates the risk of poor hearing recovery by 2%, P = .0015), and low GNRI (aOR = 1.79, P = .0435) were associated with unfavorable clinical outcomes. Conclusion: In summary, evaluation of nutritional status plays a crucial role in improving clinical outcomes in SSNHL. Moreover, GNRI can predict clinical outcomes in older patients with SSNHL treated with steroids. Older patients with SSNHL who have vertigo, a worse initial level of hearing loss, and low GNRI exhibit unfavorable outcomes. Relevance: GNRI is a simple, accessible marker that can help identify older SSNHL patients at higher risk of poor recovery. Future prospective studies should validate its use as a prognostic tool and explore whether nutritional interventions can improve hearing outcomes.
- 6 November 2025
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
Open AccessLow Geriatric Nutritional Risk Index Predicts Unfavorable Outcomes in Older Sudden Sensorineural Hearing Loss Patients
Importance: Sudden sensorineural hearing loss (SSNHL) is associated with metabolic syndrome, central obesity, and albumin level. Malnutrition may adversely affect recovery in older patients with SSNHL, yet its clinical relevance remains underexplored. Objective: This study investigated the associations of the geriatric nutritional risk index (GNRI) with clinical outcomes in older patients (age >65 years) with SSNHL. Design: Observational retrospective study. Setting: Tertiary academic medical center. Participants: A total of 328 patients aged over 65 years who were diagnosed with SSNHL were retrospectively enrolled. Patients were included if they had complete clinical, audiometric, and laboratory data, including serum albumin levels and anthropometrics for GNRI calculation. Intervention/Exposures: The primary exposure was the GNRI, calculated using body weight, height, and serum albumin. All patients received steroid treatment for SSNHL. Main Outcome Measures: The primary outcome was hearing recovery, categorized as favorable or unfavorable based on clinical audiometric improvement. Results: Among older patients with SSNHL, 107 (32.62%) and 221 (67.38%) had favorable and unfavorable outcomes, respectively. Vertigo, worse initial level of hearing loss, and low GNRI were mainly associated with unfavorable hearing outcomes in older patients with SSNHL. Furthermore, low GNRI (P = .0151). Multivariate logistic regression revealed that vertigo (aOR = 3.45, P = .0002), worse initial level of hearing loss (per 1 unit increase in hearing loss elevates the risk of poor hearing recovery by 2%, P = .0015), and low GNRI (aOR = 1.79, P = .0435) were associated with unfavorable clinical outcomes. Conclusion: In summary, evaluation of nutritional status plays a crucial role in improving clinical outcomes in SSNHL. Moreover, GNRI can predict clinical outcomes in older patients with SSNHL treated with steroids. Older patients with SSNHL who have vertigo, a worse initial level of hearing loss, and low GNRI exhibit unfavorable outcomes. Relevance: GNRI is a simple, accessible marker that can help identify older SSNHL patients at higher risk of poor recovery. Future prospective studies should validate its use as a prognostic tool and explore whether nutritional interventions can improve hearing outcomes.
- Open Access
- 11 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2006
Evaluating ChatGPT’s Concordance with Clinical Guidelines of Ménière’s Disease in Chinese
Background: Generative AI (GenAI) models like ChatGPT have gained significant attention in recent years for their potential applications in healthcare. This study evaluates the concordance of responses generated by ChatGPT (versions 3.5 and 4.0) with the key action statements from the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) clinical practice guidelines (CPGs) for Ménière’s disease translated into Chinese. Methods: Seventeen questions derived from the KAS were translated into Chinese and posed to ChatGPT versions 3.5 and 4.0. Responses were categorized as correct, partially correct, incorrect, or non-answers. Concordance with the guidelines was evaluated, and Fisher’s exact test assessed statistical differences, with significance set at p < 0.05. Comparative analysis between ChatGPT 3.5 and 4.0 was performed. Results: ChatGPT 3.5 demonstrated an 82.4% correctness rate (14 correct, 2 partially correct, 1 non-answer), while ChatGPT 4.0 achieved 94.1% (16 correct, 1 partially correct). Overall, 97.1% of responses were correct or partially correct. ChatGPT 4.0 offered enhanced citation accuracy and text clarity but occasionally included redundant details. No significant difference in correctness rates was observed between the models (p = 0.6012). Conclusions: Both ChatGPT models showed high concordance with the AAO-HNS CPG for MD, with ChatGPT 4.0 exhibiting superior text clarity and citation accuracy. These findings highlight ChatGPT’s potential as a reliable assistant for better healthcare communication and clinical operations. Future research should validate these results across broader medical topics and languages to ensure robust integration of GenAI in healthcare.
- 11 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2006
Open AccessEvaluating ChatGPT’s Concordance with Clinical Guidelines of Ménière’s Disease in Chinese
Background: Generative AI (GenAI) models like ChatGPT have gained significant attention in recent years for their potential applications in healthcare. This study evaluates the concordance of responses generated by ChatGPT (versions 3.5 and 4.0) with the key action statements from the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) clinical practice guidelines (CPGs) for Ménière’s disease translated into Chinese. Methods: Seventeen questions derived from the KAS were translated into Chinese and posed to ChatGPT versions 3.5 and 4.0. Responses were categorized as correct, partially correct, incorrect, or non-answers. Concordance with the guidelines was evaluated, and Fisher’s exact test assessed statistical differences, with significance set at p < 0.05. Comparative analysis between ChatGPT 3.5 and 4.0 was performed. Results: ChatGPT 3.5 demonstrated an 82.4% correctness rate (14 correct, 2 partially correct, 1 non-answer), while ChatGPT 4.0 achieved 94.1% (16 correct, 1 partially correct). Overall, 97.1% of responses were correct or partially correct. ChatGPT 4.0 offered enhanced citation accuracy and text clarity but occasionally included redundant details. No significant difference in correctness rates was observed between the models (p = 0.6012). Conclusions: Both ChatGPT models showed high concordance with the AAO-HNS CPG for MD, with ChatGPT 4.0 exhibiting superior text clarity and citation accuracy. These findings highlight ChatGPT’s potential as a reliable assistant for better healthcare communication and clinical operations. Future research should validate these results across broader medical topics and languages to ensure robust integration of GenAI in healthcare.
- Open Access
- 22 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (8) , 856
Breaking Sound Barriers: Exploring Tele-Audiology’s Impact on Hearing Healthcare
Hearing impairment is a global issue, affecting billions of people; however, there is a gap between the population affected by hearing loss and those able to access hearing healthcare. Tele-audiology, the application of telemedicine in audiology, serves as a new form of technology which aims to provide synchronous or asynchronous hearing healthcare. In this article, we reviewed some recent studies of tele-audiology-related topics to have a glimpse of the current development, associated challenges, and future advancement. Through the utilization of tele-audiology, patients can conveniently access hearing healthcare, and thus save travel costs and time. Recent studies indicate that remote hearing screening and intervention are non-inferior to the performance of traditional clinical pathways. However, despite its potential benefits, the implementation of tele-audiology faces numerous challenges, and audiologists have varying attitudes on this technology. Overcoming obstacles such as high infrastructure costs, limited reimbursement, and the lack of quality standards calls for concerted efforts to develop effective strategies. Ethical concerns, reimbursement, and patient privacy are all crucial aspects requiring in-depth discussion. Enhancing the education and training of students and healthcare workers, along with providing relevant resources, will contribute to a more efficient, systematic hearing healthcare. Future research will aim to develop integrated models with evidence-based protocols and incorporating AI to enhance the affordability and accessibility of hearing healthcare.
- 22 April 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (8) , 856
Open AccessBreaking Sound Barriers: Exploring Tele-Audiology’s Impact on Hearing Healthcare
Hearing impairment is a global issue, affecting billions of people; however, there is a gap between the population affected by hearing loss and those able to access hearing healthcare. Tele-audiology, the application of telemedicine in audiology, serves as a new form of technology which aims to provide synchronous or asynchronous hearing healthcare. In this article, we reviewed some recent studies of tele-audiology-related topics to have a glimpse of the current development, associated challenges, and future advancement. Through the utilization of tele-audiology, patients can conveniently access hearing healthcare, and thus save travel costs and time. Recent studies indicate that remote hearing screening and intervention are non-inferior to the performance of traditional clinical pathways. However, despite its potential benefits, the implementation of tele-audiology faces numerous challenges, and audiologists have varying attitudes on this technology. Overcoming obstacles such as high infrastructure costs, limited reimbursement, and the lack of quality standards calls for concerted efforts to develop effective strategies. Ethical concerns, reimbursement, and patient privacy are all crucial aspects requiring in-depth discussion. Enhancing the education and training of students and healthcare workers, along with providing relevant resources, will contribute to a more efficient, systematic hearing healthcare. Future research will aim to develop integrated models with evidence-based protocols and incorporating AI to enhance the affordability and accessibility of hearing healthcare.
- 22 December 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 170 (3) , 675-693
Endoscopic Versus Microscopic Type I Tympanoplasty: An Updated Systematic Review and Meta‐analysis
Objective: Our objective was to perform a systematic review and meta‐analysis comparing the clinical outcomes after endoscopic and microscopic type I tympanoplasty.Study Design: Randomized controlled trials, two‐arm prospective studies, and retrospective studies were included.Setting: Medline, Cochrane, EMBASE, and Google Scholar databases were searched until March 1, 2022 using the combinations of search terms: “endoscopic,” “microscopic,” and “tympanoplasty.”Methods: Two independent reviewers utilized the abovementioned search strategy to identify eligible studies. If any uncertainty existed regarding eligibility, a third reviewer was consulted. Primary outcome measures were graft success rate, air‐bone gap (ABG) improvement, and operative time. Secondary outcomes were the rate of need for canalplasty, the proportion of self‐rated excellent cosmetic results, and pain visual analog scale (VAS).Results: Forty‐three studies enrolled a total of 3712 patients who were undergoing type I tympanoplasty and were finally included. The pooled result showed endoscopic approach was significantly associated with shorter operative time (difference in means: −20.021, 95% confidence interval [CI]: −31.431 to −8.611), less need for canalplasty (odds ratio [OR]: 0.065, 95% CI: 0.026‐0.164), more self‐rated excellent cosmetic results (OR: 87.323, 95% CI: 26.750‐285.063), and lower pain VAS (difference in means: −2.513, 95% CI: −4.737 to −0.228). No significant differences in graft success rate or ABG were observed between the two procedures.Conclusion: Endoscopic type I tympanoplasty provides a similar graft success rate, improvement in ABG, and reperforation rate to microscopic tympanoplasty with a shorter operative time, better self‐rated cosmetic results, and less pain. Unless contraindicated, the endoscopic approach should be the procedure of choice in type I tympanoplasty.
- 22 December 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 170 (3) , 675-693
Endoscopic Versus Microscopic Type I Tympanoplasty: An Updated Systematic Review and Meta‐analysis
Objective: Our objective was to perform a systematic review and meta‐analysis comparing the clinical outcomes after endoscopic and microscopic type I tympanoplasty.Study Design: Randomized controlled trials, two‐arm prospective studies, and retrospective studies were included.Setting: Medline, Cochrane, EMBASE, and Google Scholar databases were searched until March 1, 2022 using the combinations of search terms: “endoscopic,” “microscopic,” and “tympanoplasty.”Methods: Two independent reviewers utilized the abovementioned search strategy to identify eligible studies. If any uncertainty existed regarding eligibility, a third reviewer was consulted. Primary outcome measures were graft success rate, air‐bone gap (ABG) improvement, and operative time. Secondary outcomes were the rate of need for canalplasty, the proportion of self‐rated excellent cosmetic results, and pain visual analog scale (VAS).Results: Forty‐three studies enrolled a total of 3712 patients who were undergoing type I tympanoplasty and were finally included. The pooled result showed endoscopic approach was significantly associated with shorter operative time (difference in means: −20.021, 95% confidence interval [CI]: −31.431 to −8.611), less need for canalplasty (odds ratio [OR]: 0.065, 95% CI: 0.026‐0.164), more self‐rated excellent cosmetic results (OR: 87.323, 95% CI: 26.750‐285.063), and lower pain VAS (difference in means: −2.513, 95% CI: −4.737 to −0.228). No significant differences in graft success rate or ABG were observed between the two procedures.Conclusion: Endoscopic type I tympanoplasty provides a similar graft success rate, improvement in ABG, and reperforation rate to microscopic tympanoplasty with a shorter operative time, better self‐rated cosmetic results, and less pain. Unless contraindicated, the endoscopic approach should be the procedure of choice in type I tympanoplasty.
- 18 April 2023
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 236, 107557
Quantitative transmastoid ultrasound for detecting middle ear effusion in pediatric patients
- 18 April 2023
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 236, 107557
Quantitative transmastoid ultrasound for detecting middle ear effusion in pediatric patients